Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
81,000
Employees81,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
81,000
Employees81,000

PFE Key Statistics

Market cap
146.90B
Market cap146.90B
Price-Earnings ratio
18.41
Price-Earnings ratio18.41
Dividend yield
6.52%
Dividend yield6.52%
Average volume
43.15M
Average volume43.15M
High today
$25.86
High today$25.86
Low today
$25.83
Low today$25.83
Open price
$25.74
Open price$25.74
Volume
38.27K
Volume38.27K
52 Week high
$31.54
52 Week high$31.54
52 Week low
$24.48
52 Week low$24.48

PFE News

Sherwood News 18h
German court rules Pfizer violated Moderna Covid vaccine patent, sending Moderna even higher

German court rules Pfizer violated Moderna Covid vaccine patent, sending Moderna even higher Moderna shares are rising after a German court handed the vaccine...

German court rules Pfizer violated Moderna Covid vaccine patent, sending Moderna even higher
TipRanks 3d
Pfizer comments on Q1, Q2 numbers amid higher rebate expense

Says “I don’t think the Street” has adjusted yet and that “they should have a look on it.” The company says the rebates that Pfizer (PFE) will be asked to be in...

Benzinga 6d
Analyst Downgrades LAVA Therapeutics, Sees Pipeline Overhang

On Tuesday, LAVA Therapeutics N.V. LVTX initiated a process to review strategic options. The company implemented cost curtailment, including a workforce reduct...

Analyst Downgrades LAVA Therapeutics, Sees Pipeline Overhang

Analyst ratings

57%

of 23 ratings
Buy
39.1%
Hold
56.5%
Sell
4.3%

More PFE News

Seeking Alpha 6d
Pfizer is latest Big Pharma to overhaul DEI goals after GSK

Pfizer (NYSE:PFE) has made significant updates to its diversity, equity, and inclusion (DEI) webpage, becoming the latest Big Pharma after GSK (NYSE:GSK) to rev...

Pfizer is latest Big Pharma to overhaul DEI goals after GSK
Simply Wall St 6d
Market Still Lacking Some Conviction On Pfizer Inc.

It's not a stretch to say that Pfizer Inc.'s ( ) price-to-earnings (or "P/E") ratio of 18.4x right now seems quite "middle-of-the-road" compared to the market i...

Market Still Lacking Some Conviction On Pfizer Inc.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.